Tiefenbacher Group Career Stories No 2
"Get to know Johanna Hansen, AI Project Manager at Tiefenbacher Group!"
At Tiefenbacher Group, it’s our people who shape innovation, company culture and our impact on patients around the world. That’s why we’re excited to continue our video series giving you a behind-the-scenes look at the individuals who make Tiefenbacher a unique place to work and grow.
In this episode
Johanna shares her journey from starting with Tiefenbacher as a dual student to gaining experience in multiple roles and departments over the years, leading to her current position as AI Project Manager.
“What truly motivates me is that Tiefenbacher invests in individual growth while making affordable medicines available. When you can see how the pharmacy projects you have worked on come to life and create a real impact for patients around the world, that’s amazing.” – Johanna Hansen
Curious to know more? Watch the video below and discover what makes Tiefenbacher Group a top choice for building your career.
About Tiefenbacher Group – Pioneering Healthcare since 1963
Tiefenbacher Group is a purpose-driven and 100% family-owned healthcare company providing best-in-class solutions along the entire pharmaceutical value chain. From the initial idea to market access of high-quality medicines around the world: We distribute APIs and develop, produce, and register finished dosage forms (FDFs) including highly potent drugs as well as medical devices. Our purpose is to improve people’s lives by making pharmaceuticals more affordable, more available, and better than ever before.
For further information about TIEFENBACHER GROUP and our solutions for better healthcare and our in-house capabilities to develop and commercialize pharmaceutical products for global markets (including highly potent drugs) please contact us by email at info@tiefenbacher.com or visit us on: www.tiefenbachergroup.com
Tiefenbacher Group Career Stories No 1
"Get to know Sayan Sarkar, Head of Global Digitalization & AI at Tiefenbacher Group!"
At Tiefenbacher Group, it’s our employees who shape innovation, company culture, and impact on patients around the world. That’s why we’re excited to launch a new video series giving you a behind-the-scenes look at the people working at Tiefenbacher.
In this episode
Sayan Head of Global Digitalization & AI shares what drives him, how he started his journey with us, and what makes working at Tiefenbacher Group so special.
“What motivates me to work here every day is the direct impact we create on people’s lives, especially where our products are the lifeline for many protected groups, e.g. children.”- Sayan Sarkar
Curious to know more? Watch the video below and discover what makes Tiefenbacher Group a unique place to grow.
About Tiefenbacher Group – Pioneering Healthcare since 1963
Tiefenbacher Group is a purpose-driven and 100% family-owned healthcare company providing best-in-class solutions along the entire pharmaceutical value chain. From the initial idea to market access of high-quality medicines around the world: We distribute APIs and develop, produce, and register finished dosage forms (FDFs) including highly potent drugs as well as medical devices. Our purpose is to improve people’s lives by making pharmaceuticals more affordable, more available, and better than ever before.
For further information about TIEFENBACHER GROUP and our solutions for better healthcare and our in-house capabilities to develop and commercialize pharmaceutical products for global markets (including highly potent drugs) please contact us by email at info@tiefenbacher.com or visit us on: www.tiefenbachergroup.com
Tiefenbacher New Market Launch: Buprenorphine Patches in South Africa
Tiefenbacher Pharmaceuticals successfully prepared the launch of the analgesic Buprenorphine as Transdermal Patch in South Africa.
We at Tiefenbacher Pharmaceuticals strongly believe that our high-quality medicines should be affordable and available for all patients around the world. That´s why we are thrilled to share that we have successfully prepared the launch of the generic version of the analgesic Buprenorphine as transdermal patch in South Africa.
Affordable Medicines are therapeutically equivalent to their branded counterparts with a lower price due to losing patent protection. The low costs of generic medications promote patient affordbility and contribute to lower per capita healthcare spendings.
Buprenorphine
is part of the opioid analgesics class and is used to help relieve severe, long-lasting pain – for example, caused by arthritis or chronic back conditions. To support patients with such conditions, our cooperation partner has marketed the transdermal patches in strengths of 5 mcg, 10 mcg, and 20 mcg. These have already been successfully launched in several international markets before.
The successful launch of this affordable medicine is a testament to the hard work and dedication of our team. We are particularly excited about the positive impact for the South African healthcare system and look already forward to further market entries of our high-quality medicines.
TIEFENBACHER PHARMACEUTICALS, a part of Tiefenbacher Group, develops and commercializes generic, value added, and innovative pharmaceuticals as well as medical devices and e-health-solutions worldwide. We provide over 180+ pharmaceutical products across various therapeutic categories in 10+ dosage forms. With our in-house product development and manufacturing, we can address specific therapeutic needs in unique formulations of prescription drugs (Rx) and over-the-counter (OTC) medicines for global markets.
For more information about our finished dosage forms (FDF) including highly potent drugs and e-healthcare solutions, please contact us at info@tiefenbacher.com or visit us on www.tiefenbacher-pharmaceuticals.com
About Tiefenbacher Group – Pioneering Healthcare since 1963
Tiefenbacher Group is a purpose-driven and 100% family-owned healthcare company. We are providing best-in-class solutions along the entire pharmaceutical value chain. From the initial idea to market access of high-quality medicines around the world: We distribute APIs and develop, produce, and register finished dosage forms (FDFs) including highly potent drugs as well as medical devices and e-health solutions. The purpose is to improve people’s lives by making pharmaceuticals more affordable, more available, and better than ever before.
For further information about TIEFENBACHER GROUP please contact us by email at info@tiefenbacher.com or visit us on: www.tiefenbachergroup.com
Tiefenbacher Group Self-Care Day
At Tiefenbacher Group, we believe that a healthier workplace starts with healthier people.
That’s why we dedicated a full Self-Care Day to one of the most overlooked pillars of workplace well-being: spinal health. With the support of Dr. Subhadra Rani, we hosted a holistic Yoga session at Tiefenbacher Laboratories in Hyderabad focusing on preventive techniques for Sciatica and Spondylitis, which are two common conditions that affect mobility and energy levels, especially in sedentary work environments.
Through gentle stretches, awareness exercises, and breathing techniques, our colleagues were introduced to practical tools they can integrate into everyday life.
Why this matters?
- 75% of adults experience back pain at some point in their lives
- Regular movement and posture awareness can prevent chronic issues
- Mindful breaks during work reduce stress and increase focus
- Team-based activities promote a caring and connected workplace culture
We’re proud to support initiatives like these that bring science, movement, and community together.
About Tiefenbacher Group – Pioneering Healthcare since 1963
Tiefenbacher Group is a purpose-driven and 100% family-owned healthcare company providing best-in-class solutions along the entire pharmaceutical value chain. From the initial idea to market access of high-quality medicines around the world:
We distribute APIs and develop, produce, and register finished dosage forms (FDFs) including highly potent drugs as well as medical devices. The purpose is to improve people’s lives by making pharmaceuticals more affordable, more available, and better than ever before.
For further information about TIEFENBACHER GROUP and our solutions for better healthcare and our in-house capabilities to develop and commercialize pharmaceutical products for global markets (including highly potent drugs) please contact us by email at info@tiefenbacher.com or visit us on: www.tiefenbachergroup.com
Pioneering Healthcare at Tiefenbacher Group
Curiosity Driven, Excellence Focused, Patient Centered
At Tiefenbacher Group, we believe that our expertise must be leveraged for the greater good – to improve patients’ lives worldwide by pioneering healthcare. Our core values of being CURIOSITY DRIVEN, EXCELLENCE FOCUSED, and PATIENT CENTERED guide our actions and decisions every day. These values help us achieve our purpose of making high-quality pharmaceuticals more affordable, more available, and better than ever before.
But what does it mean to be “excellence focused”? We asked our TIEFENBACHER GROUP Managing Director, Dr. Kristian Ruepp, to elaborate:
How does Tiefenbacher Group’s commitment to being “Patient Centered” shape your approach to pharmaceutical development?
It starts with asking questions and then just listening – to patients, doctors, nurses, payers and many more stakeholders. When you then add a genuine curiosity to understand the challenges in the lives of patients and a motivation to challenge the status quo, then we always find great ideas for new development projects.
Can you provide examples of how Tiefenbacher ensures its products are accessible and affordable for patients, and why these aspects are essential to your mission?
In terms of accessibility we see many countries worldwide, in which highly important pharmaceuticals have never been launched by big pharma companies and patients therefore have no access to these therapeutic options. In many cases we are the first to launch such pharmaceuticals with our partners in such countries and provide access to these valuable drugs to patients.
Affordability of pharmaceuticals is a main driver behind generics or better affordable medicines. Without the savings, which off-patent, affordable medicines deliver to the societies, there would be no money left to fund new innovative drugs. At Tiefenbacher we are mainly driven by being the first to offer more affordable medicines and supplying the markets reliably at a highly competitive price.
With our development capabilities, our global supplier network and our manufacturing sites we are a driver to make medicines more affordable together with our marketing partners.
How does Tiefenbacher Group incorporate patient feedback and insights from healthcare professionals into its products and services?
One example comes into my mind with this question. Several years back, we heard from patients and doctors that a well-known pharmaceutical for treating a disease of the central nervous system causes severe gastro intestinal side effects for many patients in their life-long treatment. We understood that the reason for these side effects was based on the highly reactive chemical structure of this pharmaceutical substance.
We decided to develop a pro-drug to reduce these sides effects. Today we are very happy that we received the marketing authorization in Europe and could prove in a safety study that we reduce significantly these gastric side effects. Many patients will benefit from our idea and this pharmaceutical help patients live a healthier life.
At Tiefenbacher Group, the focus on excellence is the foundation of our pioneering approach to healthcare. We are excited about the future and remain committed to improving patients´ lives globally.
Feel free to reach out for more insights into our journey or to join us in pioneering the future of healthcare!
About Tiefenbacher Group – Pioneering Healthcare since 1963
Tiefenbacher Group is a purpose-driven and 100% family-owned healthcare company providing best-in-class solutions along the entire pharmaceutical value chain. From the initial idea to market access of high-quality medicines around the world: We distribute APIs and develop, produce, and register finished dosage forms (FDFs) including highly potent drugs as well as medical devices and e-health solutions. The purpose is to improve people’s lives by making pharmaceuticals more affordable, more available, and better than ever before.
For further information about TIEFENBACHER GROUP and our solutions for better healthcare and our in-house capabilities to develop and commercialize pharmaceutical products for global markets (including highly potent drugs) please contact us by email at info@tiefenbacher.com or visit us on: www.tiefenbachergroup.com
Tiefenbacher Group Hamburg Triathlon 2025
Tiefenbacher Group at Hamburg Triathlon 2025 crossing the finish line.
Last weekend, our team took on the challenge of the Hamburg Wasser World Triathlon 2025 right in the heart of Hamburg!
From the swim in the Alster to the bike ride through the city and the final push across the finish line, our colleagues showed true determination, endurance, and teamspirit.
The atmosphere was simply incredible
The Hamburg Triathlon has been a highlight in the global triathlon calendar since 2002 and is one of the world’s largest triathlon events, attracting over 10,000 athletes and 250,000 spectators each year. As part of the World Triathlon Championship Series, it brings together professionals and amateurs alike in an electric atmosphere that turns Hamburg into a festival of fitness and resilience.
We’re proud of everyone who participated and cheered along the sidelines. You’ve inspired us all!
About Tiefenbacher Group – Pioneering Healthcare since 1963
Tiefenbacher Group is a purpose-driven and 100% family-owned healthcare company providing best-in-class solutions along the entire pharmaceutical value chain. From the initial idea to market access of high-quality medicines around the world:
We distribute APIs and develop, produce, and register finished dosage forms (FDFs) including highly potent drugs as well as medical devices. The purpose is to improve people’s lives by making pharmaceuticals more affordable, more available, and better than ever before.
For further information about TIEFENBACHER GROUP and our solutions for better healthcare and our in-house capabilities to develop and commercialize pharmaceutical products for global markets (including highly potent drugs) please contact us by email at info@tiefenbacher.com or visit us on: www.tiefenbachergroup.com
Tiefenbacher Group about affordable medicines
Why are affordable medicines so important for healthcare?
Did you know that affordable (generic) medicines represent the majority of treatments in Europe, accounting for 70% of the treatment volume and 19% of the market value in 2023? They play a crucial role in ensuring patient well-being and public health by providing safe, effective, and affordable treatments. Without the competition created by affordable medicines, European healthcare payers would have had to spend an additional €120 billion in 2023 alone.*
IQVIA summarizes 4 value dimensions of affordable medicines:
Economic Value
- Support predictable and sustainable spending growth for healthcare systems
- Provide reliable future savings for payers
- Reduce co-payments for patients
Access
- Expand access to major chronic therapy areas
- Help to reduce disease burden in underserved markets
Supply Chain
- Mitigate the risk of shortages through multi-source supply
- 9 in 10 critical medicines are affordable medicines
Innovation
- Value added (affordable) medicines offer a range of unique benefits to patients
- Stimulate continued innovation from originators
At Tiefenbacher Group, we are proud to contribute to sustainable healthcare by developing and supplying high-quality affordable, valueadded, and innovative medicines. Our commitment goes beyond cost savings, it’s about making essential medicines accessible to more patients, ensuring treatment continuity, and fostering pharmaceutical innovation to improve patients`lives around the world.
*(Sources: IQVIA Beneath the Surface; OECD – OCDE Indicators Report; The Center for Biosimilars AAM Report; Medicines for Europe)
About Tiefenbacher Group – Pioneering Healthcare since 1963
Tiefenbacher Group is a purpose-driven and 100% family-owned healthcare company providing best-in-class solutions along the entire pharmaceutical value chain. From the initial idea to market access of high-quality medicines around the world: We distribute APIs and develop, produce, and register finished dosage forms (FDFs) including highly potent drugs as well as medical devices and e-health-solutions. Our purpose is to improve people’s lives by making pharmaceuticals more affordable, more available, and better than ever before.
For further information about our solutions for better healthcare and our in-house capabilities to develop and commercialize pharmaceutical products (including highly potent drugs) and e-health-solutions for global markets, please contact us by email at info@tiefenbacher.com or visit us on: www.tiefenbachergroup.com
Tiefenbacher Group International Social Day
TIEFENBACHER SOCIAL DAY GOES GLOBAL
Last week marked a very special moment for all of us at Tiefenbacher Group. It was our very first international SocialDay.
Across all our locations, from Hamburg to Hyderabad to Nicosia, hundreds of colleagues stepped out of their daily routines to support meaningful social, environmental, and community initiatives. Whether helping at Katholische Kindertagesstätte St.Marien, Millerntor Gallery, Tafel Buxtehude, alsterdorf assistenz ost, Kinder-Hospiz Sternenbrücke, or volunteering with Hanseatic Help e.V., DER HAFEN HILFT! e. V., Green Kayak, the Cyprus Red Cross Society, ΟΚΥπΥ – State Health Services Organisation , Hamburger Tierschutzverein von 1841 e.V., and Sri Vidhas Centre for Special Children. Each contribution has made a real difference and shown what it means to live our values and take responsibility beyond the workplace.
Our caring culture is the key
A big thank you to everyone who participated. Your commitment, energy, and TeamSpirit made this day an inspiring expression of our shared values at Tiefenbacher Group.
We are especially grateful to our Management Team for making this day possible. A sincere thanks to Anna Demetriou and Farzana Mohammed for organizing everything with dedication and heart. A special shoutout to Marie-Theres Blumers for your tireless support, the organization of this day and the enthusiasm you brought to this project.
Our caring culture is key to achieving our purpose of making everyday life significantly better for people around the world. We will continue to support initiatives that strengthen communities and promote health in line with our values.
Continuing a Tradition of Caring
Taking on social responsibility is a core aspect of the Tiefenbacher Group’s culture. Our commitment to community engagement and social initiatives is crucial to our mission of making a positive impact on the lives of people and the planet. We will continue to support charitable activities, education programs, and community engagement efforts that align with our values.
Looking Back and Moving Forward
Our journey began in 2022 with a successful Clean Up Day, where we cleared 100 kilograms of garbage from a small area in Hamburg. In 2023, we expanded this initiative by launching the first Tiefenbacher Social Day, giving all our Hamburg employees the chance to support social projects with their colleagues.
The Second Tiefenbacher Social Day
Last year, the second Tiefenbacher Social Day commenced, offering a variety of projects for our employees to choose from. These projects ranged from environmental protection to supporting aid organizations and social institutions such as hospices, retirement homes, and services for the homeless and refugees.
Making a Valuable Contribution
There are countless projects that do incredible work but often lack the necessary budget or rely heavily on volunteers. By dedicating our time and efforts on this special day, we at the Tiefenbacher Group can help bring these projects to life, making a valuable contribution to people, the environment, and society.
We are proud of our team’s dedication and look forward to continuing our tradition of social responsibility in the years to come. Thank you to everyone who participated and made this day a success. Together, we can make a significant difference.
About Tiefenbacher Group – Pioneering Healthcare since 1963
Tiefenbacher Group is a purpose-driven and 100% family-owned healthcare company providing best-in-class solutions along the entire pharmaceutical value chain. From the initial idea to market access of high-quality medicines around the world: We distribute APIs and develop, produce, and register finished dosage forms (FDFs) including highly potent drugs as well as medical devices and e-health solutions. The purpose is to improve people’s lives by making pharmaceuticals more affordable, more available, and better than ever before.
For further information about TIEFENBACHER GROUP and our solutions for better healthcare and our in-house capabilities to develop and commercialize pharmaceutical products for global markets (including highly potent drugs) please contact us by email at info@tiefenbacher.com or visit us on: www.tiefenbachergroup.com
Tiefenbacher Group Celebrating International Yoga Day
Tiefenbacher Group is celebrating International Yoga Day with Young Minds in India
We are delighted to share that our colleagues from Tiefenbacher Laboratories celebrated International Yoga Day this week at Sardar Vallabhbhai Patel Primary School, located near our Indian facilities in Hyderabad.
The event was a great success, with 40 enthusiastic children, 10 dedicated volunteers from Tiefenbacher Laboratories, and supportive teachers taking part. The children practiced Surya Namaskar, Chakrasana, Bhujangasana, and Mandukasana, embracing the essence of yoga with energy and joy. They were also encouraged to learn about the many benefits of yoga and how it can positively impact their daily lives and overall health.
Tiefenbacher Group long-term commitment
Sardar Vallabhbhai Patel Primary School has around 80 students and is proudly supported by Tiefenbacher Group. This initiative is part of our long-term commitment to providing access to quality education and healthcare, driving sustainable social impact where it is needed most.
About Tiefenbacher Group – Pioneering Healthcare since 1963
Tiefenbacher Group is a purpose-driven and 100% family-owned healthcare company providing best-in-class solutions along the entire pharmaceutical value chain. From the initial idea to market access of high-quality medicines around the world:
We distribute APIs and develop, produce, and register finished dosage forms (FDFs) including highly potent drugs as well as medical devices. The purpose is to improve people’s lives by making pharmaceuticals more affordable, more available, and better than ever before.
For further information about TIEFENBACHER GROUP and our solutions for better healthcare and our in-house capabilities to develop and commercialize pharmaceutical products for global markets (including highly potent drugs) please contact us by email at info@tiefenbacher.com or visit us on: www.tiefenbachergroup.com
Tiefenbacher Group Football Cup 2025
The Tiefenbacher Group Football Cup 2025 winner is “The Lawn Mowers”
This year, more than 200 people (employees and their families) turned up to join the Tiefenbacher Group Football Cup. They spent a wonderful sunny day full of team spirit, playing football together and great vibes.
After a gripping group stage, the final saw “The Lawn Mowers” take on “Red Flags”, with “The Lawn Mowers” clinching the win in a 3:1 victory! Congratulations Paul-Kester Schulz, Katharina Wolff, Hassan Tufail, Oliver Schrader 🇺🇦, Meelad Akam, Jennifer Detlefsen, Kristian Ruepp, and Richard Baderin for winning this year’s Tiefenbacher Cup!
The atmosphere was simply incredible
A huge thank you to Ulrike Klingberg & Florian Herb for organizing such a fantastic event, and of course to everyone who helped make it happen behind the scenes.
With food, drinks, and music rounding off the day, the atmosphere was simply incredible. We’re already counting down the days to next year’s tournament!
About Tiefenbacher Group – Pioneering Healthcare since 1963
Tiefenbacher Group is a purpose-driven and 100% family-owned healthcare company providing best-in-class solutions along the entire pharmaceutical value chain. From the initial idea to market access of high-quality medicines around the world:
We distribute APIs and develop, produce, and register finished dosage forms (FDFs) including highly potent drugs as well as medical devices. The purpose is to improve people’s lives by making pharmaceuticals more affordable, more available, and better than ever before.
For further information about TIEFENBACHER GROUP and our solutions for better healthcare and our in-house capabilities to develop and commercialize pharmaceutical products for global markets (including highly potent drugs) please contact us by email at info@tiefenbacher.com or visit us on: www.tiefenbachergroup.com
